Genetic contribution to late-stage cancer treatment resistance identified
New research has identified some factors that may lead to some skin cancers no longer responding to treatment. Published in Cancer...
Genetic contribution to late-stage cancer treatment resistance identified
Melanoma rates lower in patients with atopic diseases
Investigational melanoma vaccine receives breakthrough designation from U.S. FDA
Methotrexate use associated with increased risk of some skin cancers
Fewer cases of melanoma seen in people taking vitamin D
Highest risk of multiple primary melanomas from indoor tanning
Models predict low mortality in certain patients with stage 1 melanoma
Relatlimab/nivolumab combo improves melanoma outcomes, may avoid surgery